Evidence map›Paper›PMID 32108165›Full record

ArticleOncogene2020

Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species.

Sahba Kasiri, Baozhi Chen, Alexandra N Wilson, Annika Reczek, Simbarashe Mazambani, Jashkaran Gadhvi, Evan Noel, Ummay Marriam, Barbara Mino, Wei Lu and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Sahba Kasiri *Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
Baozhi Chen *Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
Alexandra N WilsonNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
Annika ReczekNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
Simbarashe MazambaniDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, TX, 75080, USA.
Jashkaran GadhviDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, TX, 75080, USA.
Evan NoelNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
Ummay MarriamNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
Barbara MinoDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Wei LuDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Luc GirardNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
Luisa M SolisDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-1253-630X
Katherine Luby-PhelpsDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Justin BishopDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Jung-Whan KimDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, TX, 75080, USA.
James KimNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA. james.kim@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-2992-9222
Harold C. Simmons Comprehensive Cancer CenterThe University of Texas at Dallas · USThe University of Texas MD Anderson Cancer Center · USThe University of Texas Southwestern Medical Center · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4M
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASET32HL098040 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAUL, PHILIP W, TERADA, LANCE S · 2009 to 2024
$4.6M
Targeting vismodegib-resistant tumors using BH3 mimeticsR01CA196851 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI KIM, JAMES · 2016 to 2020
$1.7M
(PQ9) Prevention of Bleomycin-induced Pulmonary Toxicity by Dichloroacetate (DCA)R21CA208746 · NCI · UNIVERSITY OF TEXAS DALLAS · PI KIM, JUNG-WHAN · 2016 to 2017
$372k
NCI NIH HHS P50 CA070907NCI NIH HHS R01 CA196851NCI NIH HHS R21 CA208746NHLBI NIH HHS T32 HL098040
6 · The paper itself

Abstract

Activation of the Hedgehog (Hh) signaling pathway by mutations within its components drives the growth of several cancers. However, the role of Hh pathway activation in lung cancers has been controversial. Here, we demonstrate that the canonical Hh signaling pathway is activated in lung stroma by Hh ligands secreted from transformed lung epithelia. Genetic deletion of Shh, the primary Hh ligand expressed in the lung, in Kras

Indexed as

AcetylcysteineAdenocarcinoma of LungAnimalsAntibodies, Anti-IdiotypicBlood VesselsCell ProliferationDNA DamageGene Expression Regulation, NeoplasticHedgehog ProteinsHumansLigandsLungMiceMutationNeoplasm MetastasisProto-Oncogene Proteins p21(ras)AcetylcysteineAntibodies, Anti-IdiotypicHedgehog ProteinsHras protein, mouseihh protein, mouseLigandsProto-Oncogene Proteins p21(ras)Reactive Oxygen SpeciesShh protein, mouseTrp53 protein, mouseTumor Suppressor Protein p53

Identifiers

PMID32108165
PMCPMC7160060
OpenAlexW3008914281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.